NM_153717.3:c.1320T>A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_153717.3(EVC):​c.1320T>A​(p.Phe440Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00888 in 1,614,164 control chromosomes in the GnomAD database, including 158 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0077 ( 13 hom., cov: 34)
Exomes 𝑓: 0.0090 ( 145 hom. )

Consequence

EVC
NM_153717.3 missense

Scores

1
1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.635
Variant links:
Genes affected
EVC (HGNC:3497): (EvC ciliary complex subunit 1) This gene encodes a protein containing a leucine zipper and a transmembrane domain. This gene has been implicated in both Ellis-van Creveld syndrome (EvC) and Weyers acrodental dysostosis. [provided by RefSeq, Jul 2008]
CRMP1 (HGNC:2365): (collapsin response mediator protein 1) This gene encodes a member of a family of cytosolic phosphoproteins expressed exclusively in the nervous system. The encoded protein is thought to be a part of the semaphorin signal transduction pathway implicated in semaphorin-induced growth cone collapse during neural development. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.001494199).
BP6
Variant 4-5753789-T-A is Benign according to our data. Variant chr4-5753789-T-A is described in ClinVar as [Benign]. Clinvar id is 167043.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-5753789-T-A is described in Lovd as [Benign]. Variant chr4-5753789-T-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00773 (1177/152296) while in subpopulation EAS AF= 0.0492 (254/5160). AF 95% confidence interval is 0.0443. There are 13 homozygotes in gnomad4. There are 581 alleles in male gnomad4 subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 13 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EVCNM_153717.3 linkc.1320T>A p.Phe440Leu missense_variant Exon 10 of 21 ENST00000264956.11 NP_714928.1 P57679

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EVCENST00000264956.11 linkc.1320T>A p.Phe440Leu missense_variant Exon 10 of 21 1 NM_153717.3 ENSP00000264956.6 P57679
EVCENST00000509451.1 linkc.1320T>A p.Phe440Leu missense_variant Exon 10 of 12 1 ENSP00000426774.1 E9PCN4
EVCENST00000514919.1 linkn.383T>A non_coding_transcript_exon_variant Exon 2 of 2 2
CRMP1ENST00000506216.5 linkn.1648-5477A>T intron_variant Intron 12 of 12 5

Frequencies

GnomAD3 genomes
AF:
0.00773
AC:
1176
AN:
152178
Hom.:
13
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00275
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0153
Gnomad ASJ
AF:
0.00519
Gnomad EAS
AF:
0.0491
Gnomad SAS
AF:
0.00414
Gnomad FIN
AF:
0.00584
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00679
Gnomad OTH
AF:
0.00574
GnomAD3 exomes
AF:
0.0146
AC:
3661
AN:
251462
Hom.:
79
AF XY:
0.0126
AC XY:
1707
AN XY:
135898
show subpopulations
Gnomad AFR exome
AF:
0.00234
Gnomad AMR exome
AF:
0.0440
Gnomad ASJ exome
AF:
0.00566
Gnomad EAS exome
AF:
0.0584
Gnomad SAS exome
AF:
0.00291
Gnomad FIN exome
AF:
0.00508
Gnomad NFE exome
AF:
0.00622
Gnomad OTH exome
AF:
0.0103
GnomAD4 exome
AF:
0.00899
AC:
13149
AN:
1461868
Hom.:
145
Cov.:
30
AF XY:
0.00853
AC XY:
6204
AN XY:
727238
show subpopulations
Gnomad4 AFR exome
AF:
0.00158
Gnomad4 AMR exome
AF:
0.0397
Gnomad4 ASJ exome
AF:
0.00536
Gnomad4 EAS exome
AF:
0.0487
Gnomad4 SAS exome
AF:
0.00282
Gnomad4 FIN exome
AF:
0.00490
Gnomad4 NFE exome
AF:
0.00730
Gnomad4 OTH exome
AF:
0.00982
GnomAD4 genome
AF:
0.00773
AC:
1177
AN:
152296
Hom.:
13
Cov.:
34
AF XY:
0.00780
AC XY:
581
AN XY:
74474
show subpopulations
Gnomad4 AFR
AF:
0.00274
Gnomad4 AMR
AF:
0.0154
Gnomad4 ASJ
AF:
0.00519
Gnomad4 EAS
AF:
0.0492
Gnomad4 SAS
AF:
0.00414
Gnomad4 FIN
AF:
0.00584
Gnomad4 NFE
AF:
0.00679
Gnomad4 OTH
AF:
0.00568
Alfa
AF:
0.00798
Hom.:
7
Bravo
AF:
0.0100
TwinsUK
AF:
0.00593
AC:
22
ALSPAC
AF:
0.00545
AC:
21
ESP6500AA
AF:
0.00272
AC:
12
ESP6500EA
AF:
0.00651
AC:
56
ExAC
AF:
0.0127
AC:
1544
Asia WGS
AF:
0.0250
AC:
87
AN:
3478
EpiCase
AF:
0.00578
EpiControl
AF:
0.00587

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Apr 03, 2014
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jun 01, 2016
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Nov 07, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Ellis-van Creveld syndrome Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 16, 2020
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome Benign:1
Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.81
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
6.6
DANN
Benign
0.94
DEOGEN2
Benign
0.15
T;.
Eigen
Benign
-0.82
Eigen_PC
Benign
-0.82
FATHMM_MKL
Benign
0.034
N
LIST_S2
Benign
0.64
T;T
MetaRNN
Benign
0.0015
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.6
L;.
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-2.1
N;N
REVEL
Benign
0.11
Sift
Benign
1.0
T;T
Sift4G
Benign
0.19
T;T
Polyphen
0.0080
B;.
Vest4
0.12
MutPred
0.34
Gain of glycosylation at S437 (P = 0.0158);Gain of glycosylation at S437 (P = 0.0158);
ClinPred
0.0063
T
GERP RS
-2.3
Varity_R
0.12
gMVP
0.25

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.12
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs60582583; hg19: chr4-5755516; API